This is done by reviewing aberrant 5-HT1A receptor functioning in epilepsy, noting that 5-MeO-DMT has notable 5-HT1A receptor agonist properties—and then comparing the acute behavioral and subjective effects induced by 5-MeO-DMT to those that occur in seizures.
What is Plikli?
Plikli is an open source content management system that lets you easily create your own user-powered website.
Latest Comments
Log in to comment or register here.